Latest Asx News

Avenira Limited has ended its licensing agreement with Aleees, freeing the company to focus on a phased development of its Wonarah Phosphate Project aimed at early revenue generation in late 2025.

OD6 Metals has raised A$1.17 million through a targeted share placement to fund high-impact exploration at the historic Gulf Creek Copper Project, with drilling set to begin imminently.

Superior Resources has identified compelling high-grade copper, gold, and silver mineralisation at the historic Halls Reward Mine, revealing significant unmined extensions and multiple new targets for exploration.

Beacon Minerals has secured key regulatory approvals to launch multiple drilling programs at its Lady Ida Iguana Project, setting the stage for intensified exploration activity over the coming months.

Forrestania Resources has secured $360,000 through a non-brokered placement, attracting a new major shareholder and setting the stage for expanded gold exploration at its Bonnie Vale project.

Estrella Resources has reported exceptional manganese assay results from its Lautém Project in Timor-Leste, revealing grades up to 58.6% Mn and paving the way for imminent drilling activities.

FireFly Metals reports outstanding high-grade copper-gold intersections from its aggressive six-rig drilling campaign at the Green Bay Project, aiming to expand and upgrade its mineral resources significantly.

Strata Minerals has secured $1.6 million through an equity placement to fund its maiden drilling campaign at the Penny South Gold Project, targeting extensions of high-grade gold deposits near Ramelius Resources’ operations.

Cosmo Metals has secured an exclusive option to acquire the high-grade Bingara and Nundle gold, antimony, and copper projects in northern NSW, backed by a $1.6 million underwritten capital raising to fund initial exploration.

New Zealand Coastal Seafoods Limited has raised $18,000 through a convertible note subscription, reinforcing its financial position and enabling accelerated strategic initiatives focused on sustainable seafood.

New Zealand Coastal Seafoods reports a sharp reduction in losses following the closure of its New Zealand operations and reveals promising initial fishing results in the Coral Sea. The company is actively exploring commercial opportunities for its Coral Sea Fishery permits and a potential acquisition to boost future revenues.

Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.